By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aclaris Therapeutics 

101 Lindenwood Drive
Suite 400
Malvern  Pennsylvania  19355  U.S.A.
Phone: 484-324-7933 Fax: 484-324-7949



Company News
Aclaris (ACRS) To Announce Third Quarter 2016 Financial Results On November 3, 2016 10/25/2016 8:12:33 AM
Aclaris (ACRS) Release: New Observational Study Demonstrates Patient Impact Of Seborrheic Keratosis, A Common, Undertreated Skin Condition Affecting 83.8 Million Americans 10/19/2016 8:09:37 AM
Aclaris (ACRS) To Present At The Morgan Stanley 2016 Healthcare Conference 9/6/2016 10:39:32 AM
Aclaris (ACRS) Announces Positive Results In Phase II Clinical Trial Of A-101 For Treatment Of Common Warts 8/18/2016 8:03:11 AM
Aclaris (ACRS) Reports Second Quarter 2016 Financial Results 8/11/2016 11:23:01 AM
Aclaris (ACRS) Announces Appointment Of Bill Humphries To Board Of Directors 8/5/2016 10:36:44 AM
Aclaris (ACRS) To Announce Second Quarter 2016 Financial Results On August 11, 2016 8/2/2016 8:19:28 AM
Aclaris (ACRS) To Ring The Nasdaq Stock Market Closing Bell 7/25/2016 8:54:42 AM
Aclaris (ACRS) Completes Enrollment Of Phase 3 Pivotal Trials Of A-101 For The Treatment Of Seborrheic Keratosis (SK); Provides Update On Clinical Programs 7/25/2016 8:53:45 AM
Aclaris (ACRS) Appoints Kevin Scott As Vice President Of Sales 5/5/2016 8:09:10 AM